Eden Research (LON:EDEN) Stock Price Down 3.3% – Should You Sell?

Eden Research plc (LON:EDEN)’s stock price was down 3.3% on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares were traded during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The firm’s fifty day moving average price is GBX 3.87 and its two-hundred day moving average price is GBX 3.95.

Insider Activity at Eden Research

In related news, insider Alexander John Abrey purchased 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction that occurred on Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,958.74). 14.02% of the stock is owned by corporate insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.